Moderna researchers did not test their COVID-19 mRNA drug, called SPIKEVAX, to find out where it would go in our bodies (biodistribution). Instead, their biodistribution study was for a completely different vaccine. Despite this substitution of one drug study for another, the U.S. Food and Drug Administration (FDA) approved SPIKEVAX […]
Introducing Disease X: An ‘Innocent’ Vaccine Program Waiting for a New Illness
Many people all over the world never want to hear the word “vaccine” again after the COVID-19 vaccine debacle. Yet, with new mRNA biotechnology ready at the computer screen for the next genetic code to come in, you can see how vaccine ideologists cannot wait for another pandemic to test […]
Report 75: mRNA COVID “Vaccines” Have Created a New Class of Multi-Organ/System Disease: “CoVax Disease.” Children from Conception on Suffer Its Devastating Effects. – Histopathology Series – Part 4d
This report is Part 4d in a series. It follows Part 1, “Report 56: Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus;” Part 2, “Report 58: Part 2 – “Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus;” and Part 3, […]
COVID mRNA Vaccine LINKED to Acute Myopericarditis
COVID mRNA Vaccine LINKED to Acute Myopericarditis Background Post-vaccination myopericarditis is reported after immunization with coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccines. The effect of inadvertent intravenous injection of this vaccine on the heart is unknown. Methods We compared the clinical manifestations, histopathological changes, tissue mRNA expression, and serum […]
Report 22: Effects of N1-Methyl-Pseudouridine in the Pfizer mRNA Vaccine
Daily Clout 5/9/22 Report: Effects of N1-methyl-pseudouridine in the Pfizer mRNA Vaccine Researcher/Author: Daniel B. Demers, PhD Reviewed by: Team 5 Introduction The use of messenger RNA (mRNA) vaccines has been developing since 1990. Historically, there have been three significant problems associated with mRNA vaccines. First, it has always been […]
Report 03: Phase 1 /2 Study of COVID-19 RNA Vaccine BNT162b1 in Adults: Key Processes Missing.
Mulligan, Lyke et al. Nature Published online August 12, 2020. Cite this article as: Mulligan, M. J. et al. Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults. Nature https://doi.org/10.1038/s41586-020-2639-4 (2020). P1 p2: The authors’ put forth the argument that mRNA in BNT162b1 (Note this series used BNT162b1 […]